 limb
ischemia. J Vasc Surg 1997;26:629-37.
69. Ballard JL, Eke CC, Bunt TJ, Killeen JD. A prospective evaluation
of transcutaneous oxygen measurements in the management of
diabetic foot problems. J Vasc Surg 1995;22:485-90; discussion:
490-2.
70. Braun JD, Trinidad-Hernandez M, Perry D, Armstrong DG, Mills JL.
Early quantitative evaluation of indocyanine green angiography in
patients with critical limb ischemia. J Vasc Surg 2013;57:1213-8.
71. McGraw KO, Wong SP. Forming inferences about some intraclass
correlation coefÔ¨Åcients. Psychol Methods 1996;1:30-46.
72. Cronenwett JL, Likosky DS, Russell MT, Eldrup-Jorgensen J,
Stanley AC, Nolan BW, et al. A regional registry for quality assurance
and improvement: the Vascular Study Group of Northern New
England (VSGNNE). J Vasc Surg 2007;46:1093-101.
73. Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS,
et al. Use of alternative methodologies for evaluation of composite end
points in trials of therapies for critical limb ischemia. Am Heart J
2012;164:277-84.
74. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR,
Moneta GL, et al. Suggested objective performance goals and clinical
trial design for evaluating catheter-based treatment of critical limb
ischemia. J Vasc Surg 2009;50:1462-73.
75. Bertele V, Roncaglioni MC, Pangrazzi J, Terzian E, Tognoni G.
Clinical outcome and its predictors in 1560 patients with critical leg
ischaemia. Eur J Vasc Endovasc Surg 1999;18:401-10.
